
Advancing immunotherapy through biology-driven AI
UNLOCKING THE POWER OF IMMUNOTHERAPY
Our functional immunomics platform generates the cleanest, most actionable biological data — the data that AI models need to deliver faster, more accurate discoveries and translate them into therapies with confidence.
At Feromics, our scientists, engineers, and clinicians begin where the science demands — with function. Most platforms collect molecular data first and search for functional meaning afterward. Feromics inverts that sequence entirely. We identify and isolate immune cells based on what they actually do in the context of a specific disease — before any molecular data is collected, before any model is trained. That functional selection changes the quality of everything that follows. The molecular data is cleaner. The AI models train faster. The discoveries translate.
Every data point carries a verified functional outcome — the signal is already there, labeled and confirmed, before the AI ever sees it. With standard genomic data, models sift through noise — averaging, correlating, searching for patterns that may or may not be meaningful. Feromics data is pre-filtered by biology. The noise is removed at the source. The result: cleaner data, faster training, and discoveries that translate.

EXPERTISE
Immunotherapy
Identifying the functional pathways that drive immune cell behavior in cancer and autoimmune disease — generating the biological intelligence that accelerates the development of next-generation therapies.
Precision Medicine
Derisking preclinical and clinical development through functional immune profiling — optimizing efficacy, predicting patient response, and enabling personalized treatment selection based on each patient's unique immune profile.
Donor Intelligence: Identifying and selecting high-performance donors for allogeneic cell therapies based on verified functional killing data — ensuring the cells going into manufacturing are the cells most likely to produce durable clinical outcomes.
OUR APPROACH
Our science is different. Our workflow is different. Our technology is different.
Starting with our proprietary Intelligent Design™ platform and function-first discovery workflow, we identify and isolate immune cells based on directly observed functional behavior — before any molecular data is collected, before any model is trained. This produces high-signal, disease-specific datasets that feed directly into AI models, accelerating discoveries with clarity and confidence.
This highly targeted data powers our AI-driven bioinformatics, enabling advanced AI and deep-learning models trained on functional, disease-specific immune cell data — ensuring models learn from the biology itself, not just what cells contain.

